Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-013137
Filing Date
2017-03-07
Accepted
2017-03-07 12:40:20
Documents
3
Period of Report
2017-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v461307_6k.htm 6-K 23567
2 GRAPHIC image_001.jpg GRAPHIC 4141
3 GRAPHIC image_002.jpg GRAPHIC 4141
  Complete submission text file 0001144204-17-013137.txt   36265
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 17671156
SIC: 2834 Pharmaceutical Preparations